Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Assessment of systemic corticosteroid activity

R G Dluhy1

  • 1Brigham & Women's Hospital, Boston, MA 02115, USA.

Respiratory Medicine
|February 25, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Glucocorticoid-remediable aldosteronism is associated with severe hypertension in early childhood.

The Journal of pediatrics·2001
Same author

Glucocorticoid-remediable aldosteronism and pregnancy.

Hypertension (Dallas, Tex. : 1979)·2000
Same author

Glucocorticoid-remediable aldosteronism.

The Journal of clinical endocrinology and metabolism·1999
Same author

Corticosteroid treatment of asthma: now at the crossroads. Reply to Drs Seale and Donnelly.

Respiratory medicine·1999
Same author

Effect of inhaled beclomethasone dipropionate and budesonide on adrenal function, skin changes and cataract formation.

Respiratory medicine·1999
Same author

The biology and clinical relevance of somatostatin receptor scintigraphy in adrenal tumor management.

The Yale journal of biology and medicine·1998

Inhaled corticosteroids (ICS) generally pose no risk of adrenal crisis, even during stress. Low to medium doses show minimal HPA axis suppression, making acute adrenal insufficiency extremely unlikely in patients.

Area of Science:

  • Endocrinology
  • Pulmonology
  • Pharmacology

Background:

  • Inhaled corticosteroids (ICS) are widely used for managing respiratory conditions.
  • Concerns exist regarding the potential impact of ICS on the hypothalamic-pituitary-adrenal (HPA) axis.
  • Understanding the risk of adrenal insufficiency with ICS use is crucial for patient safety.

Purpose of the Study:

  • To evaluate the risk of adrenal crisis in patients using inhaled corticosteroids.
  • To determine the relationship between ICS dosage, duration, and HPA axis effects.
  • To assess the likelihood of acute adrenal insufficiency in patients on ICS therapy.

Main Methods:

  • Review of existing literature on inhaled corticosteroid effects on the HPA axis.
  • Analysis of factors influencing HPA axis suppression, including ICS potency and dose.

Related Experiment Videos

  • Assessment of adrenal crisis risk based on the degree of HPA axis suppression.

    • Main Results:

    • ICS potency, dose, and treatment duration influence HPA axis effects.
    • Minimal to modest HPA axis suppression is observed at low/medium ICS doses.
    • The risk of adrenal crisis is considered extremely unlikely with standard ICS use.

    Conclusions:

    • In patients using inhaled corticosteroids, the risk of acute adrenal insufficiency and subsequent adrenal crisis is very low.
    • Low/medium doses of ICS are associated with minimal HPA axis suppression, mitigating the risk of adrenal crisis.
    • Clinical management should consider these findings to reassure patients and guide therapy.